Increased incidence of squamous cell carcinoma of the skin after long-term treatment with azathioprine in patients with auto-immune inflammatory rheumatic diseases

Journal of the European Academy of Dermatology and Venereology

Volumn 28, Issue 1, 2014, Pages 27-33

  Van Den Reek, J M P A ^a   Van Lumig P P M ^a   Janssen, M ^b   Schers, H J ^a   Hendriks, J C M ^a   Van De Kerkhof, P C M ^a   Seyger, M M B ^a   De Jong, E M G J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RIJNSTATE HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ETANERCEPT; GLUCOCORTICOID; GOLD; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; PENICILLAMINE; PREDNISONE; SALAZOSULFAPYRIDINE;

ADOLESCENT; ADULT; AGED; ANKYLOSING SPONDYLITIS; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE INFLAMMATORY RHEUMATIC DISEASE; CANCER INCIDENCE; CANCER PATIENT; CANCER RISK; CHRONIC DISEASE; COHORT ANALYSIS; COMPARATIVE STUDY; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DERMATOMYOSITIS; DISCOID LUPUS ERYTHEMATOSUS; ENTEROPATHY; FEMALE; FOLLOW UP; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MIXED CONNECTIVE TISSUE DISEASE; NON MELANOMA SKIN CANCER; POLYARTHRITIS; POLYCHONDRITIS; POLYMYOSITIS; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; RHEUMATIC DISEASE; RISK FACTOR; SJOEGREN SYNDROME; SKIN CARCINOMA; SPONDYLOARTHROPATHY; SYSTEMIC LUPUS ERYTHEMATOSUS; TEMPORAL ARTERITIS; TERTIARY CARE CENTER; TREATMENT DURATION; VASCULITIS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; AZATHIOPRINE; CARCINOMA, SQUAMOUS CELL; CHILD; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; SKIN NEOPLASMS; YOUNG ADULT;

EID: 84890555688     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/jdv.12041     Document Type: Article

References (27)

1. Austin AS, Spiller RC,. Inflammatory bowel disease, azathioprine and skin cancer: case report and literature review. Eur J Gastroenterol Hepatol 2001; 13: 193-194.
2. Bouhnik Y, Lémann M, Mary J-Y, et al. Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine. Lancet 1996; 347: 215-219.
3. Wu JJ, Orengo IF,. Squamous cell carcinoma in solid-organ transplantation. Dermatol online J 2002; 8: 4.
4. Keller B, Braathen LR, Marti HP, et al. Skin cancers in renal transplant recipients: a description of the renal transplant cohort in Bern. Swiss Med Wkly 2010; 140: w13036.
5. Ulrich C, Kanitakis J, Stockfleth E, et al. Skin cancer in organ transplant recipients - where do we stand today?. American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2008; 8: 2192-2198.
6. Zwald FO, Brown M,. Skin cancer in solid organ transplant recipients: advances in therapy and management: part II. Management of skin cancer in solid organ transplant recipients. J Am Acad Dermatol 2011; 65: 263-279; quiz 80.
7. Setshedi M, Epstein D, Winter TA, et al. Use of thiopurines in the treatment of inflammatory bowel disease is associated with an increased risk of non-melanoma skin cancer in an at-risk population: a cohort study. J Gastroenterol Hepatol 2012; 27: 385-389.
8. Smith MA, Irving PM, Marinaki AM, et al. Review article: malignancy on thiopurine treatment with special reference to inflammatory bowel disease. Aliment Pharmacol Ther 2010; 32: 119-130.
9. Ridky TW,. Nonmelanoma skin cancer. J Am Acad Dermatol 2007; 57: 484-501.
10. Jensen P, Moller B, Hansen S,. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol 2000; 42: 307.
11. Sulica VI, Kao GF,. Squamous-cell carcinoma of the scalp arising in lesions of discoid lupus erythematosus. Am J Dermatopathol 1988; 10: 137-141.
12. Dabski K, Stoll HL Jr, Milgrom H,. Squamous cell carcinoma complicating late chronic discoid lupus erythematosus. J Surg Oncol 1986; 32: 233-237.
13. Bourke JF, Mellott GJ, Young M, et al. Skin cancer in an Irish renal transplant population. Ir J Med Sci 1992; 161: 116-117.
14. Kinlen LJ,. Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment. Am J Med 1985; 78: 44-49.
15. Karagas MR, Cushing GL Jr, Greenberg ER, et al. Non-melanoma skin cancers and glucocorticoid therapy. Br J Cancer 2001; 85: 683-686.
16. Naldi L,. Malignancy concerns with psoriasis treatments using phototherapy, methotrexate, cyclosporin, and biologics: facts and controversies. Clin Dermatol 2010; 28: 88-92.
17. Stern RS, Laird N,. The carcinogenic risk of treatments for severe psoriasis. Photochemotherapy Follow-up Study. Cancer 1994; 73: 2759-2764.
18. Björnadal L, Löfström B, Yin L, et al. Increased cancer incidence in a Swedish cohort of patients with systemic lupus erythematosus. Scand J Rheumatol 2002; 31: 66-71.
19. Chakravarty EF, Michaud K, Wolfe F,. Skin cancer, rheumatoid arthritis, and tumor necrosis factor inhibitors. J Rheumatol 2005; 32: 2130-2135.
20. Dreyer L, Faurschou M, Mogensen M, et al. High incidence of potentially virus-induced malignancies in systemic lupus erythematosus: a long-term followup study in a Danish cohort. Arthritis Rheum 2011; 63: 3032-3037.
21. Casparie M, Tiebosch AT, Burger G, et al. Pathology databanking and biobanking in The Netherlands, a central role for PALGA, the nationwide histopathology and cytopathology data network and archive. Cell Oncol 2007; 29: 19-24.
22. Medicines Agency E. ICH Topic E 2 A Clinical Safety Data Management: definitions and Standards for Expedited Reporting. Approved: November 1994. URL http://www.ema.europa.eu/docs/en-GB/document-library/Scientific-guideline/2009/ 09/WC500002749.pdf. (last accessed: 20 February 2012).
23. Comprehensive Cancer Centre the Netherlands, URL http://www. cijfersonverkanker.nl consulted on (last accessed: 27 February 2012).
24. de Vries E, Coebergh JW, Van der Rhee H,. [ Trends, causes, approach and consequences related to the skin-cancer epidemic in the Netherlands and Europe ]. Ned Tijdschr Geneeskd 2006; 150: 1108-1115.
25. Schers H, Bor H, Van den Hoogen H, et al. What went and what came? Morbidity trends in general practice from the Netherlands. Eur J Gen Pract 2008; 14 (Suppl 1): 13-24.
26. Leung J, Dowling L, Obadan I, et al. Risk of non-melanoma skin cancer in autoimmune hepatitis. Dig Dis Sci 2010; 55: 3218-3223.
27. van de Lisdonk EH, van den Bosch WJHM, Lagro-Janssen ALM, Schers HJ,. Ziekten in de Huisartspraktijk. Elsevier Gezondheidszorg, Nijmegen, 2005.